Covid vaccine
The Latest
-
What To Expect When The U.S. COVID Emergency Ends On May 11
Health Secretary Xavier Becerra officially informed the state governors on Thursday that he is renewing the declaration a final time but plans to let the emergency expire come May 
Health Secretary Xavier Becerra officially informed the state governors on Thursday that he is renewing the declaration a final time but plans to let the emergency expire come May -
Is It The Right Time For The U.S. To Stop Buying COVID Shots?
The U.S. will transition the federal Covid vaccination program to the private market as soon as the fall, according to latest reports 
The U.S. will transition the federal Covid vaccination program to the private market as soon as the fall, according to latest reports -
Study Finds Vaccinated Lactating Moms’ Breast Milk Tainted With COVID Vaccines
Mothers and would-be moms who haven't been vaccinated against COVID would be glad to know they didn't get jabbed after a new study found something very interesting-even concerning. 
Mothers and would-be moms who haven't been vaccinated against COVID would be glad to know they didn't get jabbed after a new study found something very interesting-even concerning. -
Pfizer Pill Becomes First COVID-19 Treatment Approved By FDA
Paxlovid, produced by Pfizer, was shown in clinical trials to reduce the chance of severe sickness by 90%. 
Paxlovid, produced by Pfizer, was shown in clinical trials to reduce the chance of severe sickness by 90%. -
U.S. FDA Could Authorize COVID-19 Anti-Viral Treatment This Week
Both pills are administered as at-home treatment for those with a higher risk of getting COVID-19. Both pills are administered as at-home treatment for those with a higher risk of getting COVID-19. -
Pfizer Says Its COVID-19 Antiviral Pill Drastically Cuts Hospitalization And Death
The Pfizer pills are mixed with the older antiviral ritonavir and are taken every 12 hours for five days. The Pfizer pills are mixed with the older antiviral ritonavir and are taken every 12 hours for five days. -
Pfizer's COVID-19 Immunity Protection Drops After Two Months -- Study
A 90% success rate was observed after Pfizer's second dose of prevention against hospitalization and death. 
A 90% success rate was observed after Pfizer's second dose of prevention against hospitalization and death. -
Pfizer COVID-19 Vaccine Loses Effectiveness Over Time, Scientists Say
The vaccine's efficacy in preventing hospitalization and death remained high for at least six months, researchers say. 
The vaccine's efficacy in preventing hospitalization and death remained high for at least six months, researchers say. -
Joe Biden Receives His COVID-19 Booster On Camera
The CDC and the FDA backed a booster shot of Pfizer's vaccine last week for individuals 65 years and older. 
The CDC and the FDA backed a booster shot of Pfizer's vaccine last week for individuals 65 years and older. -
Pfizer CEO Predicts Life 'Back To Normal' Within A year
Pfizer's stock price climbed from $30.99 on March 8, 2020 to $43.94 on Monday. 
Pfizer's stock price climbed from $30.99 on March 8, 2020 to $43.94 on Monday.
